BioVie's market cap is currently $10.93M. The company's EPS TTM is $-3.952; its P/E ratio is -0.16; BioVie is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
